Child pages
  • HER2 and trastuzumab treatment response H&E slides with tumor ROI annotations (HER2 tumor ROIs)

Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Yale trastuzumab response cohort: The response 85 response cohort cases were identified also by retrospective search of the Yale Pathology electronic database. Cases included those patients with a pre-treatment breast core biopsy with HER2 positive invasive breast carcinoma who then received neoadjuvant targeted therapy with trastuzumab +/- pertuzumab prior to definitive surgery. HER2 positivity was defined as previously described for the HER2 negative/positive cohort. The response to targeted therapy was obtained from the pathology reports of the surgical resection specimens and dichotomized into responders or non-responders. Those with a complete pathologic response, defined as no residual invasive, lymphovascular invasion or metastatic carcinoma, were designated as responders (n=36). Cases with only residual in situ carcinoma were included in the responder category. Those cases with any amount of residual invasive carcinoma, lymphovascular invasion or metastatic carcinoma were categorized as non-responders (n=49).

TCGA HER2 cohort: A total of 668 TCGA-BRCA HER2+/- samples with available HER2 status were downloaded from the GDC portal (see "Additional Resources" below). Slides were visually inspected by our pathology team to exclude low quality samples with tissue folding or those that appeared to be from frozen tissue. A total of 187 samples (92 HER2- and 95 HER2+) were retained for use as independent test set.

Localtab Group


Localtab
activetrue
titleData Access

Data Access

Data TypeDownload all or Query/FilterLicense

Tissue Slide Images (SVS,40GB)

ROI Annotations (XML)


Tcia button generator
urlhttps://faspex.cancerimagingarchive.net/aspera/faspex/external_deliveries/278?passcode=4ee5d71f5adb4f116b72e3cab18abc6c4a037e5b


(Download requires Aspera)

Tcia cc by 4

Clinical data (CSV)Image Removed


Tcia cc by 4

Click the Versions tab for more info about data releases.

Additional Resources

Genomic Data Commons:

The NCI Cancer Research Data Commons (CRDC) provides access to additional data and a cloud-based data science infrastructure that connects data sets with analytics tools to allow users to share, integrate, analyze, and visualize cancer research data.

  • Genomic Data Commons Legacy Archive (Tissue Slide Images)
    • TCGA HER2 cohort: A total of 668 TCGA-BRCA HER2+/- samples with available HER2 status were downloaded from the GDC portal. Slides were visually inspected by our pathology team to exclude low quality samples with tissue folding or those that appeared to be from frozen tissue. A total of 187 samples (92 HER2- and 95 HER2+) were retained for use as independent test set.

Click the Versions tab for more info about data releases.

Please contact help@cancerimagingarchive.net  with any questions regarding usage.


Localtab
titleDetailed Description

Detailed Description

Image Statistics


Modalities

Pathology

Number of Patients

273

Number of Images

273

Images Size (GB)40




Localtab
titleCitations & Data Usage Policy

Citations & Data Usage Policy

Tcia limited license policy

Info
titleData Citation

Farahmand, Saman, Fernandez, Aileen I, Ahmed, Fahad Shabbir, Rimm, David L., Chuang, Jeffrey H., Reisenbichler, Emily, & Zarringhalam, Kourosh. (2022). HER2 and trastuzumab treatment response H&E slides with tumor ROI annotations (Version 1) [Data set]. The Cancer Imaging Archive. https://doi.org/10.7937/E65C-AM96


Info
titlePublication Citation

Farahmand, S., Fernandez, A.I., Ahmed, F.S. et al. Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer. Mod Pathol (2021). https://doi.org/10.1038/s41379-021-00911-w


Info
titleTCIA Citation

Clark K, Vendt B, Smith K, Freymann J, Kirby J, Koppel P, Moore S, Phillips S, Maffitt D, Pringle M, Tarbox L, Prior F. The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository, Journal of Digital Imaging, Volume 26, Number 6, December, 2013, pp 1045-1057. DOI: 10.1007/s10278-013-9622-7

Other Publications Using This Data

TCIA maintains a list of publications which leverage TCIA data. If you have a manuscript you'd like to add please contact the TCIA Helpdesk.


Localtab
titleVersions

Version 1 (Current): Updated 2022/03/25

Data TypeDownload all or Query/FilterLicense

Tissue Slide Images (SVS,40GB)

ROI Annotations (XML)


Tcia button generator
urlhttps://faspex.cancerimagingarchive.net/aspera/faspex/external_deliveries/278?passcode=4ee5d71f5adb4f116b72e3cab18abc6c4a037e5b


(Download requires Aspera)

Tcia cc by 4

Clinical
Data
data (CSV)

Tcia cc by 4